INS and Insulin resistance: Luteolin and its glycoside derivative significantly improve glycemic parameters (fasting glucose, HbA1c, insulin levels, and homeostatic model assessment of insulin resistance) in diabetic KKAy mice, with luteolin outperforming its glucosylated form [18].